Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dalhoff

Showing results (51-60 of 104) with videos related to

Pageof 11
Sort By:
Infection|January 1, 1988
Ciprofloxacin concentrations in tonsils following single or multiple administrationsN Falser, A Dalhoff, H Weuta
The Journal of Infectious Diseases|October 1, 1983
Nonspecific induction of beta-lactamase in Enterobacter cloacaeW Cullmann, W Dick, A Dalhoff
Infection|September 1, 1984
Ciprofloxacin concentrations in tonsils following a single intravenous infusionN Falser, A Dalhoff, H Weuta
Antimicrobial Agents and Chemotherapy|February 15, 2017
Pharmacodynamics of Finafloxacin, Ciprofloxacin, and Levofloxacin in Serum and Urine against TEM- and SHV-Type Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Isolates from Patients with Urinary Tract InfectionsA Dalhoff, S Schubert, A Vente
Chemotherapy|July 30, 2003
Target affinities of faropenem to and its impact on the morphology of gram-positive and gram-negative bacteriaA Dalhoff, T Nasu, K Okamoto
Infection|January 1, 1988
Pharmacokinetics of ciprofloxacinT Bergan, A Dalhoff, R Rohwedder
Chemotherapy|September 25, 2003
Beta-lactamase stability of faropenemA Dalhoff, T Nasu, K Okamoto
Infection|March 7, 2006
Effect of pH on the in vitro activity of and propensity for emergence of resistance to fluoroquinolones, macrolides, and a ketolideA Dalhoff, S Schubert, U Ullmann
Chemotherapy|March 1, 1995
Effect of quinolones against slowly growing bacteriaA Dalhoff, S Matutat, U Ullmann
Infection|January 1, 1983
The granuloma pouch: an in vivo model for pharmacokinetic and chemotherapeutic investigations. II. Microbiological characterizationA Dalhoff, G Frank, G Luckhaus
Pageof 11

Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
Infection|January 1, 1988
Ciprofloxacin concentrations in tonsils following single or multiple administrationsN Falser, A Dalhoff, H Weuta
The Journal of Infectious Diseases|October 1, 1983
Nonspecific induction of beta-lactamase in Enterobacter cloacaeW Cullmann, W Dick, A Dalhoff
Infection|September 1, 1984
Ciprofloxacin concentrations in tonsils following a single intravenous infusionN Falser, A Dalhoff, H Weuta
Antimicrobial Agents and Chemotherapy|February 15, 2017
Pharmacodynamics of Finafloxacin, Ciprofloxacin, and Levofloxacin in Serum and Urine against TEM- and SHV-Type Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Isolates from Patients with Urinary Tract InfectionsA Dalhoff, S Schubert, A Vente
Chemotherapy|July 30, 2003
Target affinities of faropenem to and its impact on the morphology of gram-positive and gram-negative bacteriaA Dalhoff, T Nasu, K Okamoto
Infection|January 1, 1988
Pharmacokinetics of ciprofloxacinT Bergan, A Dalhoff, R Rohwedder
Chemotherapy|September 25, 2003
Beta-lactamase stability of faropenemA Dalhoff, T Nasu, K Okamoto
Infection|March 7, 2006
Effect of pH on the in vitro activity of and propensity for emergence of resistance to fluoroquinolones, macrolides, and a ketolideA Dalhoff, S Schubert, U Ullmann
Chemotherapy|March 1, 1995
Effect of quinolones against slowly growing bacteriaA Dalhoff, S Matutat, U Ullmann
Infection|January 1, 1983
The granuloma pouch: an in vivo model for pharmacokinetic and chemotherapeutic investigations. II. Microbiological characterizationA Dalhoff, G Frank, G Luckhaus
Pageof 11